Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Perfusion|December 7, 2020
Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolismChristopher Gaisendrees, Sebastian G Walter, Ahmed Elderia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicityBoris Böll, Farag Eltaib, Katrin S Reiners, et al.
Annals of Hematology|November 17, 2022
Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysisJorge Garcia Borrega, Boris Böll, Matthias Kochanek, et al.
European Journal of Haematology|June 27, 2024
Marked hyperferritinemia in critically ill cancer patientsPaul Liedgens, Jan-Michel Heger, Noelle Sieg, et al.
British Journal of Haematology|December 29, 2018
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trialBoris Böll, Annette Plütschow, Carolin Bürkle, et al.
Mycoses|April 28, 2020
COVID-19 associated pulmonary aspergillosisPhilipp Koehler, Oliver A Cornely, Bernd W Böttiger, et al.
European Journal of Haematology|September 3, 2022
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)Sarah Gillessen, Annette Pluetschow, Vladan Vucinic, et al.
Blood|January 31, 2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Indra Thielen, Heinz Haverkamp, et al.
Microorganisms|September 28, 2021
Clinical Course and Outcome of Patients with SARS-CoV-2 Alpha Variant Infection Compared to Patients with SARS-CoV-2 Wild-Type Infection Admitted to the ICUJorge Garcia Borrega, Jan-Hendrik Naendrup, Katrin Heindel, et al.
Blood|February 3, 2016
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trialsBoris Böll, Helen Goergen, Karolin Behringer, et al.
Pageof 10